Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.
The New England journal of medicine 2018 05 21() doi 10.1056/NEJMoa1804093 Abstract Background Dupilumab is a fully human anti-interleukin-4 receptor α monoclonal antibody that blocks both interleukin-4 and interleukin-13...
Read More